Unknown

Dataset Information

0

Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance.


ABSTRACT: The aim of the present study was to investigate the underlying mechanisms of methotrexate (MTX) resistance in the human osteosarcoma cell line, Saos-2/MTX4.4, and to evaluate various methods of overcoming the resistance to this chemotherapeutic agent. MMT assays were performed to determine the resistance of the primary (Saos-2) and resistant (Saos-2/MTX4.4) cell lines to MTX, cisplatin [cis-diamminedichloroplatinum II (DDP)], ifosfamide (IFO), Adriamycin (ADM), epirubicin (EPI) and theprubicin (THP). The Saos-2/MTX4.4 cells exhibited a low resistance to IFO, ADM, EPI and THP; however, no resistance to DDP was identified. Overall, the Saos-2/MTX4.4 cells exhibited a greater resistance to all the chemotherapeutic agents investigated compared with the Saos-2 cells. Rhodamine 123 (R123) fluorescence was measured in the Saos-2/MTX4.4 and Saos-2 cells 30 and 60 min after the addition of R123, and R123 plus verapamil (VER). VER administration increased the intracellular accumulation of R123. In addition, reverse transcription-quantitative polymerase chain reaction was performed to determine the mRNA expression levels of multidrug resistance gene 1 (MDR1) in the two cell lines. Although the Saos-2/MTX4.4 cells were more resistant to the chemotherapeutic agents than the Saos-2 cells, no significant difference was identified between the relative mRNA expression levels of MDR1 in the Saos-2/MTX4.4 and Saos-2 cells (0.4350±0.0354 vs. 0.3886±0.0456; P>0.05).

SUBMITTER: Wang J 

PROVIDER: S-EPMC4301490 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance.

Wang Jianjun J   Li Guojun G  

Oncology letters 20141205 2


The aim of the present study was to investigate the underlying mechanisms of methotrexate (MTX) resistance in the human osteosarcoma cell line, Saos-2/MTX4.4, and to evaluate various methods of overcoming the resistance to this chemotherapeutic agent. MMT assays were performed to determine the resistance of the primary (Saos-2) and resistant (Saos-2/MTX4.4) cell lines to MTX, cisplatin [cis-diamminedichloroplatinum II (DDP)], ifosfamide (IFO), Adriamycin (ADM), epirubicin (EPI) and theprubicin (  ...[more]

Similar Datasets

| S-EPMC4558632 | biostudies-literature
| S-EPMC7659208 | biostudies-literature
| S-EPMC5558537 | biostudies-literature
| S-EPMC10311815 | biostudies-literature
| S-EPMC4229867 | biostudies-other
| S-EPMC6956738 | biostudies-literature
| S-EPMC10698553 | biostudies-literature
| S-EPMC5372601 | biostudies-literature
| S-EPMC3898214 | biostudies-literature
| S-EPMC7555161 | biostudies-literature